These three categories overlap clinically. The distinction comes from timeline, medication history, systemic features, and morphology — not from any single finding. Always review the medication list before attributing a rash to a viral illness.
CLINICAL PRINTABLE
Coming Soon.
Coming Soon. A one-page Viral Exanthem vs Drug Eruption clinical reference is on the way.
1 · Recognition
- Viral exanthems typically follow a viral prodrome (fever, malaise, upper respiratory symptoms) by 1–5 days. The rash is usually maculopapular, blanching, and begins centrally before spreading peripherally.
- Drug eruptions most commonly present as a morbilliform (measles-like) maculopapular rash, typically appearing 7–14 days after starting a new medication. They are often pruritic and may be widespread.
- Allergic contact dermatitis presents at the site of allergen contact — the distribution maps the exposure. Atopic dermatitis has a chronic relapsing course with flexural predilection and personal/family atopy history.
- Key distinguishing features: viral exanthem — fever precedes rash, centripetal spread, resolves with illness; drug eruption — new medication in past 4–6 weeks, widespread, may worsen after stopping; allergic/inflammatory — contact history or atopy, pruritus prominent, distribution maps exposure or flexures.
- Serious drug reactions (SJS/TEN, DRESS) must be distinguished from benign morbilliform eruptions. Red flags: mucosal involvement, skin sloughing, facial edema, systemic organ involvement (liver, kidneys, lymphadenopathy), fever with rash after a new medication.
2 · Differential / Common Traps
- Assuming viral when a new medication was started: drug eruptions are common and reversible. Always review the medication list before attributing a rash to a viral illness.
- Missing DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): DRESS can mimic a benign drug rash but involves systemic organ damage. Look for facial edema, lymphadenopathy, eosinophilia, and elevated liver enzymes in any patient with a drug rash and systemic symptoms.
- Attributing a drug eruption to a new antibiotic when the underlying infection is the actual trigger: viral infections (especially EBV/mononucleosis) can cause a morbilliform rash that is amplified by amoxicillin — this is not a true penicillin allergy.
- Missing secondary syphilis: the maculopapular rash of secondary syphilis involves the palms and soles and can mimic a drug eruption or viral exanthem. Sexual history and RPR/VDRL should be considered in the right clinical context.
- Confusing urticaria with a morbilliform drug eruption: urticaria has wheals (transient, migratory, intensely pruritic) while morbilliform eruptions have fixed macules/papules. The distinction matters for management.
3 · Workup and Interpretation
- Detailed medication history: every medication started in the past 4–6 weeks, including OTC drugs, supplements, and herbal products.
- CBC with differential: eosinophilia suggests drug reaction (especially DRESS). Atypical lymphocytes suggest viral etiology (EBV, CMV).
- Liver function tests and creatinine: in suspected DRESS, systemic organ involvement must be assessed.
- Viral serologies (EBV, CMV, parvovirus B19, enterovirus) when viral exanthem is suspected and clinical confirmation is needed — though most viral exanthems are diagnosed clinically.
- RPR/VDRL if secondary syphilis is in the differential — especially with palmoplantar involvement or mucosal lesions.
4 · Treatment / Management
Viral exanthem
Supportive care. Antipyretics for fever and discomfort. Most viral exanthems resolve within 5–10 days. No specific antiviral treatment is required for most common viral exanthems.
Morbilliform drug eruption (benign)
Identify and discontinue the offending drug when possible. Antihistamines for pruritus. Topical corticosteroids for localized discomfort. Most benign drug eruptions resolve within 1–2 weeks after stopping the drug.
DRESS
Immediate discontinuation of the offending drug. Systemic corticosteroids are the mainstay of treatment. Hospitalization for organ function monitoring. Dermatology and relevant subspecialty consultation (hepatology, nephrology) based on organ involvement.
Allergic contact dermatitis
Identify and eliminate the allergen. Topical corticosteroids for localized disease. Systemic corticosteroids for severe or widespread involvement. Patch testing for identification of the specific allergen.
Atopic dermatitis flare
Topical corticosteroids (appropriate potency for body site). Emollients and skin barrier repair. Identify and address triggers (irritants, allergens, stress, infection). Topical calcineurin inhibitors (tacrolimus, pimecrolimus) for maintenance and steroid-sparing.
5 · Expected Course / Reassessment
- Viral exanthems resolve with the underlying illness — typically within 5–10 days. No specific treatment is required.
- Benign morbilliform drug eruptions resolve within 1–2 weeks after stopping the offending drug. Pruritus may persist for several days.
- DRESS has a prolonged course — systemic organ involvement can persist for weeks to months after stopping the drug. Reactivation of HHV-6 and other herpesviruses is common.
- Contact dermatitis resolves after allergen removal — typically within 2–4 weeks with appropriate treatment.
- Atopic dermatitis is a chronic relapsing condition — flares are managed, not cured. Long-term maintenance therapy and trigger avoidance are the goals.
6 · Escalation
- Any drug rash with mucosal involvement, skin sloughing, facial edema, or systemic organ involvement — suspect SJS/TEN or DRESS. Stop the drug and escalate immediately.
- Fever + rash + lymphadenopathy + eosinophilia — DRESS workup including LFTs, creatinine, CBC. Dermatology consultation.
- Rash with hemodynamic instability or respiratory compromise — anaphylaxis or sepsis must be excluded urgently.
- Immunocompromised patient with any new rash — lower threshold for systemic workup and dermatology consultation.
Apply It · Patient Cases
CASE 1
A 22-year-old presents with a maculopapular rash 10 days after starting amoxicillin for presumed strep pharyngitis. Monospot is positive. The rash is the amoxicillin-amplified rash of EBV mononucleosis — not a true penicillin allergy. Amoxicillin is stopped, the rash resolves, and the patient is counseled that this is not a penicillin allergy.
CASE 2
A 45-year-old started allopurinol 5 weeks ago for gout. She now presents with a widespread maculopapular rash, facial edema, fever, and lymphadenopathy. CBC shows eosinophilia. LFTs are elevated. DRESS is suspected. Allopurinol is stopped immediately, systemic corticosteroids are started, and dermatology is consulted.
NOW CHANGE ONE DETAIL
Same patient as Case 2, but the rash is limited to the trunk, there is no facial edema, no lymphadenopathy, no eosinophilia, and LFTs are normal. This is a benign morbilliform drug eruption. Allopurinol is still stopped, but systemic corticosteroids are not required. Antihistamines and topical steroids are used for symptom relief.
Bottom Line
Always review the medication list before attributing a rash to a viral illness. The distinction between a benign drug eruption and DRESS is systemic organ involvement — check LFTs, creatinine, and CBC with differential.
EVIDENCE & REFERENCES
- Blumenthal KG, et al. Antibiotic allergy. N Engl J Med. 2019;381(25):2440–2451. doi:10.1056/NEJMra1807048
- Cacoub P, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588–597. doi:10.1016/j.amjmed.2011.01.017
- Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331(19):1272–1285. doi:10.1056/NEJM199411103311906